$VOR
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
Healthcare
Sector
Biotechnology
Industry
Jean-Paul Kress
CEO
159
Employees
$14.36
Current Price
$92.66M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 0 | 0 | - | - | - |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 1 | 8 | $26,918,568.57 | 1,669,542 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Apr 22, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 165,150 | $15.77 | $2,604,415.50 | View Details |
| Apr 17, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 458,411 | $16.28 | $7,462,931.08 | View Details |
| Apr 20, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 171,963 | $15.77 | $2,711,856.51 | View Details |
| Apr 14, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 153,735 | $15.97 | $2,455,147.95 | View Details |
| Apr 15, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 53,644 | $16.01 | $858,840.44 | View Details |
| Apr 13, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 530,610 | $16.15 | $8,569,351.50 | View Details |
| Apr 8, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 353,242 | $16.32 | $5,764,909.44 | View Details |
| Apr 9, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 135,201 | $16.59 | $2,242,984.59 | View Details |
| Apr 10, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 828 | $15.75 | $13,041.00 | View Details |
| Apr 8, 2026 | RA CAPITAL MANAGEMENT, L.P. Director | Sale | 130,862 | $16.91 | $2,212,876.42 | View Details |
75 more transactions available โ create a free account to see 12 months of history | ||||||
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
EstimatedN/A
ActualN/A
Revenue
EstimatedN/A
ActualN/A
3 more earnings records available โ create a free account to see 12 months of history